Trial intelligence / Profile preview

Biotin and Dexpanthenol for androgenetic alopecia

IRCT20190430043438N1Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Dec 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3 trial of biotin and dexpanthenol in androgenetic alopecia (AGA), sponsored by Tabriz University of Medical Sciences. Started Dec 2018; status: completed.

02

Drugs

biotindexpanthenol
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on IRCT20190430043438N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190430043438N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call